antibiotic g 418 has been researched along with B16 Melanoma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Guzel, AI; Kasap, H; Kasap, M; Ozcan, N; Ozgunen, K; Pazarbasi, A; Sertdemir, Y; Tuncer, I; Yilmaz, MB | 1 |
D'Aiuto, L; Huxley, C; Kotzamanis, G; Magin-Lachmann, C; Wagner, E | 1 |
Bornes, S; Couderc, B; Creancier, L; Douin, V; Favre, G; Prats, AC; Rochaix, P | 1 |
3 other study(ies) available for antibiotic g 418 and B16 Melanoma
Article | Year |
---|---|
Suppression of the tumorigenicity of B-16V melanoma cells via lysozyme gene.
Topics: Animals; Cloning, Molecular; Gene Expression Regulation, Neoplastic; Genetic Therapy; Genetic Vectors; Gentamicins; Melanoma; Melanoma, Experimental; Mice; Models, Statistical; Muramidase; Odds Ratio; Plasmids; Time Factors; Treatment Outcome | 2008 |
Retrofitting BACs with G418 resistance, luciferase, and oriP and EBNA-1 - new vectors for in vitro and in vivo delivery.
Topics: Animals; Biotechnology; Cell Line, Tumor; Chromosomes, Artificial, Bacterial; Electrophoresis, Agar Gel; Electroporation; Epstein-Barr Virus Nuclear Antigens; Escherichia coli; Gene Transfer Techniques; Genes, Reporter; Genetic Therapy; Genetic Vectors; Gentamicins; In Vitro Techniques; Luciferases; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Models, Genetic; Muscles; Plasmids; Time Factors; Transfection | 2003 |
Use and comparison of different internal ribosomal entry sites (IRES) in tricistronic retroviral vectors.
Topics: Adenocarcinoma; Animals; Antigens, CD; B7-1 Antigen; Bleomycin; CD27 Ligand; Cell Line, Tumor; Drug Resistance; Gene Expression Regulation; Gene Transfer Techniques; Genes, Viral; Genetic Vectors; Gentamicins; Humans; Kidney; Mammary Neoplasms, Animal; Melanoma; Melanoma, Experimental; Membrane Proteins; Mice; NIH 3T3 Cells; Retroviridae; Ribosomes; RNA, Messenger; Skin Neoplasms; Transduction, Genetic; Transgenes; Viral Structural Proteins | 2004 |